34 unknown. 34 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 34 | Unknown 34 |
Follow Thoracic Neoplasms: new trials by email Literature Review of Thoracic Neoplasms trials Research Report on Thoracic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat Cobicistat - Non-small Cell Lung Cancer | Phase 4 | Unknown | Maastricht University Medical Center | 60 | 2024-04-01 | 2024-08-09 |
| Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer Tislelizumab, Pemetrexed (Non-squamous NSCLC) or Nab-paclitaxel(Squamous NSCLC), Carboplatin or Cisplatin - Non-small-cell Lung Cancer (NSCLC) | Phase 4 | Unknown | The Affiliated Hospital of Qingdao University | 30 | 2024-01-18 | 2024-04-10 |
| Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine Lidocaine, Saline - Lung Neoplasms | Phase 4 | Unknown | RenJi Hospital | 92 | 2023-06-15 | 2023-05-09 |
| The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action Propofol, Sevoflurane - Lung Cancer, Brain Tumor | Phase 4 | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 1316 | 2023-05-23 | 2023-09-28 |
| Folinic Acid for Prevention of Pemetrexed-induced Toxicity Folinic acid - NSCLC, Mesothelioma | Phase 4 | Unknown | Amphia Hospital | 50 | 2023-02-06 | 2023-08-24 |
| Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status. Osimertinib - Non Small Cell Lung Cancer | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 122 | 2022-06-28 | 2023-03-27 |
| Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures Diclofenac, Placebo - Pleural Neoplasms, Aspiration, Respiratory | Phase 4 | Unknown | Assiut University | 100 | 2021-11-01 | 2021-11-16 |
| Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC Jinfukang oral liquid, Platinum-based doublet chemotherapy - Non Small Cell Lung Cancer | Phase 4 | Unknown | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 328 | 2021-10-25 | 2021-10-29 |
| Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC Recombinant human endostatin (Endostar), Thoracic irradiation of 50 Gy with 3DCRT or IMRT - Lung Cancer | Phase 4 | Unknown | Shanghai Chest Hospital | 97 | 2020-12-01 | 2020-11-03 |
| Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study Elemene plus first or third generation EGFR-TKIs, First or third generation EGFR-TKIs - Carcinoma, Non-Small-Cell Lung Cancer | Phase 4 | Unknown | Tian Xie | 744 | 2020-11-09 | 2023-12-27 |
| Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma Chemotherapy+Pembrolizumab. - Thymoma and Thymic Carcinoma | Phase 4 | Unknown | Tang-Du Hospital | 40 | 2020-08-27 | 2020-10-28 |
| Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC Gemcitabine Injectable Product - Non-small Cell Lung Cancer Metastatic | Phase 4 | Unknown | Henan Cancer Hospital | 50 | 2020-04-01 | 2020-04-02 |
| A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Thoracic Epidural Anesthesia, General Anesthesia with One Lung Ventilation - Pleural Effusion, Malignant, Pleural Mesothelioma | Phase 4 | Unknown | Mohamed Reda Ashour | 40 | 2020-01-15 | 2021-10-14 |
| Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer Zoledronic acid, Radiotherapy - Non-small Cell Lung Cancer, Bone Metastasis | Phase 4 | Unknown | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 280 | 2019-06-01 | 2019-01-16 |
| Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer Olanzapine, Placebos - Chemotherapy-induced Nausea and Vomiting, Lung Cancer | Phase 4 | Unknown | Zunyi Medical College | 156 | 2019-05-09 | 2021-07-13 |
| Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride Anlotinib Hydrochloride - Small Cell Lung Cancer | Phase 4 | Unknown | Chifeng Municipal Hospital | 30 | 2019-04-01 | 2019-03-26 |
| Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1 Nivolumab, MRI, BLOOD SAMPLES - Melanoma, Non-small Cell | Phase 4 | Unknown | Assistance Publique Hopitaux De Marseille | 50 | 2018-04-09 | 2023-04-21 |
| the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) Gefitinib Tab （CTTQ），First medication；Gefitinib Tab （CTTQ），From the 8th day of trial, Gefitinib tablets (Yi Ruisha），First medication, Gefitinib Tab 250 MG（CTTQ），From the 8th day of trial. - Non-small Cell Lung Cancer | Phase 4 | Unknown | Jiangsu Famous Medical Technology Co., Ltd. | 100 | 2017-08-01 | 2017-08-29 |
| Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma recombinant human endostatin, pemetrexed plus cisplatin or carboplatin - Adenocarcinoma of Lung | Phase 4 | Unknown | Anhui Provincial Hospital | 100 | 2016-06-01 | 2016-06-21 |
| Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD Budesonide - Post Operative Complication, Pulmonary, Lung Cancer | Phase 4 | Unknown | Xiuyi Zhi | 73 | 2015-07-01 | 2015-07-22 |
Showing 20 of 34. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (17) · Lung Neoplasms (10) · Adenocarcinoma of Lung (2) · Empyema, Pleural (2) · Pleural Neoplasms (2) · Pneumothorax (2) · Respiratory Aspiration (2) · Small Cell Lung Carcinoma (2) · Thymoma (2) · Adenocarcinoma (1) · Brain Neoplasms (1) · Carcinoma (1) · Dermatitis (1) · Disease (1) · Eczema (1)
Neoplasms (34) · Neoplasms by Site (34) · Respiratory Tract Neoplasms (32) · Respiratory Tract Diseases (30) · Lung Diseases (29) · Lung Neoplasms (22) · Bronchial Neoplasms (19) · Carcinoma, Bronchogenic (19) · Neoplasms by Histologic Type (7) · Neoplasms, Glandular and Epithelial (5) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Adenocarcinoma (2) · Adenoma (2)
Cisplatin (5) · Endostatins (4) · Pemetrexed (4) · endostar protein (4) · Carboplatin (3) · icotinib (3) · Docetaxel (2) · Erlotinib Hydrochloride (2) · Gefitinib (2) · Nivolumab (2) · Radiotherapy (2) · 130-nm albumin-bound paclitaxel (1) · Anesthesia, General (1) · Anesthesia, Inhalation (1) · Antineoplastic Agents (1)
Simcere Pharmaceutical Co., Ltd (3) · Betta Pharmaceuticals Co., Ltd. (2) · Amphia Hospital (1) · Anhui Provincial Hospital (1) · Assistance Publique Hopitaux De Marseille (1) · Assiut University (1) · Beijing Zheng Ju Medical Technology Co., Ltd. (1) · Chifeng Municipal Hospital (1) · China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (1) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Guangdong Association of Clinical Trials (1) · Henan Cancer Hospital (1) · Hunan Province Tumor Hospital (1) · Jiangsu Famous Medical Technology Co., Ltd. (1)
China (15) · Netherlands (2) · Canada (1) · Denmark (1) · Egypt (1) · France (1) · Italy (1) · Taiwan (1)
Ahmed F Koraitim, MD (1) · Bing Lu, MD (1) · Di Zheng, MD (1) · Ge Wang, Doctor (1) · Han Baohui, MD (1) · Hany H El Sayed, Professor (1) · Hu Ma, Doctor (1) · Jian Ni, MD (1) · Jianfang Xu, MD (1) · Jie Wang, PhD (1) · Jie Zhang, MD (1) · Jinming Yu, PhD (1) · Kai LI, professor (1)
PMID 19484483, PMID 23053582, PMID 23182663, PMID 29958220, PMID 31200823, PMID 35230185
2017 (1), 2023 (1)